Quintiles Transnational Holdings Inc (Q) : Ardevora Asset Management Llp scooped up 72,800 additional shares in Quintiles Transnational Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 426,000 shares of Quintiles Transnational Holdings Inc which is valued at $32,695,500.Quintiles Transnational Holdings Inc makes up approximately 1.29% of Ardevora Asset Management Llp’s portfolio.
Other Hedge Funds, Including , Oxford Asset Management sold out all of its stake in Q during the most recent quarter. The investment firm sold 41,356 shares of Q which is valued $3,174,073.Swiss National Bank boosted its stake in Q in the latest quarter, The investment management firm added 11,100 additional shares and now holds a total of 251,000 shares of Quintiles Transnational Holdings Inc which is valued at $19,337,040. Quintiles Transnational Holdings Inc makes up approx 0.03% of Swiss National Bank’s portfolio.Public Employees Retirement Association Of Colorado reduced its stake in Q by selling 1,761 shares or 8.37% in the most recent quarter. The Hedge Fund company now holds 19,287 shares of Q which is valued at $1,497,443. Quintiles Transnational Holdings Inc makes up approx 0.01% of Public Employees Retirement Association Of Colorado’s portfolio.Candriam Luxembourg S.c.a. boosted its stake in Q in the latest quarter, The investment management firm added 1,916 additional shares and now holds a total of 9,790 shares of Quintiles Transnational Holdings Inc which is valued at $734,250. Quintiles Transnational Holdings Inc makes up approx 0.02% of Candriam Luxembourg S.c.a.’s portfolio.
Quintiles Transnational Holdings Inc opened for trading at $76.4 and hit $76.71 on the upside on Monday, eventually ending the session at $76.51, with a gain of 0.14% or 0.11 points. The heightened volatility saw the trading volume jump to 6,13,148 shares. Company has a market cap of $9,065 M.
On the company’s financial health, Quintiles Transnational Holdings Inc reported $0.93 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.90. The company had revenue of $1167.10 million for the quarter, compared to analysts expectations of $1150.61 million. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.78 EPS.
Many Wall Street Analysts have commented on Quintiles Transnational Holdings Inc. Quintiles Transnational Holdings Inc was Upgraded by Avondale to ” Mkt Outperform” on Jul 12, 2016. Quintiles Transnational Holdings Inc was Downgraded by Wells Fargo to ” Market Perform” on May 12, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.